Drug name - Sumavel Dosepro

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8343130 ENDO VENTURES LTD Needleless injector Oct, 2022

(20 days from now)

US8491524 ENDO VENTURES LTD Needleless injector drug capsule and a method for filling thereof Nov, 2022

(a month from now)

US8241244 ENDO VENTURES LTD Needleless injector drug capsule and a method for filling thereof Nov, 2022

(a month from now)

US8267903 ENDO VENTURES LTD Casing Mar, 2023

(5 months from now)

US8241243 ENDO VENTURES LTD Needleless injector drug capsule and a method for filling thereof Aug, 2023

(10 months from now)

US8118771 ENDO VENTURES LTD Needleless injector drug capsule and a method for filling thereof Aug, 2023

(10 months from now)

US8287489 ENDO VENTURES LTD Device for readying a needle free injector for delivery Dec, 2024

(2 years from now)

US7901385 ENDO VENTURES LTD Casing Jul, 2026

(3 years from now)

US7776007 ENDO VENTURES LTD Device for readying a needle free injector for delivery Nov, 2026

(4 years from now)

Drugs and Companies using SUMATRIPTAN SUCCINATE ingredient

Treatment: NA

Dosage: INJECTABLE;SUBCUTANEOUS

More Information on Dosage
Strength Dosage Availability
EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML) INJECTABLE;SUBCUTANEOUS Discontinued
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) INJECTABLE;SUBCUTANEOUS Discontinued

availability in other generic markets.

Click on the highlighted region to filter.